STML
Citadel Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-88,520
| Closed | -$429K | – | 5621 |
|
|
2020
Q1 | $429K | Sell |
88,520
-636,786
| -88% | -$3.09M | ﹤0.01% | 3514 |
|
|
2019
Q4 | $7.71M | Buy |
725,306
+713,546
| +6,068% | +$7.58M | ﹤0.01% | 1334 |
|
|
2019
Q3 | $122K | Sell |
11,760
-345,651
| -97% | -$3.59M | ﹤0.01% | 4227 |
|
|
2019
Q2 | $5.48M | Buy |
357,411
+327,761
| +1,105% | +$5.02M | ﹤0.01% | 1590 |
|
|
2019
Q1 | $381K | Sell |
29,650
-437,870
| -94% | -$5.63M | ﹤0.01% | 3568 |
|
|
2018
Q4 | $4.44M | Sell |
467,520
-437,619
| -48% | -$4.16M | ﹤0.01% | 1574 |
|
|
2018
Q3 | $15M | Buy |
905,139
+80,065
| +10% | +$1.33M | 0.01% | 893 |
|
|
2018
Q2 | $13.2M | Buy |
825,074
+240,201
| +41% | +$3.86M | 0.01% | 891 |
|
|
2018
Q1 | $8.95M | Buy |
+584,873
| New | +$8.95M | ﹤0.01% | 996 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4454 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4323 |
|
|
2016
Q1 | – | Sell |
-22,397
| Closed | -$141K | – | 4212 |
|
|
2015
Q4 | $141K | Buy |
+22,397
| New | +$141K | ﹤0.01% | 3115 |
|
|
2015
Q3 | – | Sell |
-3,891
| Closed | -$46K | – | 4435 |
|
|
2015
Q2 | $46K | Buy |
3,891
+1,295
| +50% | +$15.3K | ﹤0.01% | 3448 |
|
|
2015
Q1 | $38K | Buy |
2,596
+1,323
| +104% | +$19.4K | ﹤0.01% | 3436 |
|
|
2014
Q4 | $22K | Sell |
1,273
-4,798
| -79% | -$82.9K | ﹤0.01% | 3578 |
|
|
2014
Q3 | $76K | Buy |
+6,071
| New | +$76K | ﹤0.01% | 3114 |
|
|
2013
Q4 | – | Sell |
-156,586
| Closed | -$7.09M | – | 3273 |
|
|
2013
Q3 | $7.09M | Buy |
+156,586
| New | +$7.09M | 0.01% | 823 |
|